Novo Nordisk has stopped two trials of a drug that aims to tame inflammation as a way to improve cardiovascular health, ...
Tara covers the business of health care. Her stories focus on hospitals, doctors, and how their business practices affect patients — especially when private equity gets involved. She also writes about ...
The American Diabetes Association “continues to move from crisis to crisis to crisis,” says one of five members ejected from ...
Experts agreed that the biggest threat to progress on overdose deaths is the looming Medicaid cuts. Researchers at Penn’s ...
The whole of my field has been flattened into a single lazy question: Did the health care system fail her?” writes Jennifer ...
An organ transplant first, new details on ADA conference controversy, and more health news from Morning Rounds ...
Two recipients of gene-edited pig kidneys have successfully received human organs, a milestone in the wider effort to advance ...
Ionis Pharmaceuticals on Thursday received Food and Drug Administration approval for the first disease modifying therapy for ...
A closely watched cardiovascular drug from Novartis failed in a pivotal study, the company said Friday, a major blow to the ...
At a "practice of last resort," pediatricians prioritize allaying parents' vaccine concerns without hardline dismissals.
W WASHINGTON — Hospital leaders, stung by the passage of a law that will cut nearly $1 trillion in Medicaid funding over the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results